Thursday, June 29, 2017 (CIIX) Achieves Exciting Firsts in the Global Cannabis Market

- Launched world’s first Chinese language online CBD health products store

- Launched world’s first Chinese language mobile cannabis navigation app

- Positioned to become first company in China to use CBD oil in treating epilepsy and Alzheimer’s

Pursuing its aim of becoming the leading publicly traded Chinese medical marijuana company,, Inc. (OTCQB: CIIX) continues its focus on investing in distribution and R&D of cannabidiol-based (CBD) medicines and health products targeted at Chinese-speaking clients throughout the world.

Marijuana use is currently illegal in China, but cannabis-based oils, including hemp-based CBD, are legal, giving CIIX access to a market of almost two billion potential customers in that country. CIIX is also expanding its footprint to other countries and recently incorporated CBD Biotechnology Inc. in British Columbia, Canada, which will focus on R&D and distribution of health products, including hemp-based CBD, food and beverage products there.

Additionally, CIIX officially launched a CBD online store,, in December 2016 in the free-trade zone of Shanghai, China. The site went live on January 31 and is the very first CBD health products Web store to be launched in the Chinese language, offering various CBD nutritional products, such as soft gels, capsules and concentrates. The company further plans to market a line of nutrition and food products through a brick-and-mortar store in San Gabriel, California — a predominantly Chinese-speaking area and the company’s home market (

Concurrent with the launch of, CIIX also launched the very first Chinese language mobile cannabis navigation app, which is a Yelp-style social media app containing a database of cannabis dispensaries and marijuana strains. The app also features a platform for reviewing and discussing cannabis products, maps showing marijuana dispensary locations, and summary reports of cannabis businesses in Los Angeles and other large cities. This app has already been approved by the Apple store.

CIIX’s other cannabis-related endeavors include striving to become the very first company in China to employ CBD oil as a treatment to relieve suffering for epilepsy and Alzheimer’s patients. The company plans to continue studying CBD oil’s efficacy as a treatment for these diseases and intends to invest in CBD drug R&D enterprises, with an end goal of developing a variety of CBD drugs to treat epilepsy and Alzheimer’s.

For more information, visit the company’s website at

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
480.374.1336 Office

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished:

No comments: